Cargando…
Clathrin light chain‐conjugated drug delivery for cancer
Targeted drug delivery systems hold the remarkable potential to improve the therapeutic index of anticancer medications markedly. Here, we report a targeted delivery platform for cancer treatment using clathrin light chain (CLC)‐conjugated drugs. We conjugated CLC to paclitaxel (PTX) through a gluta...
Autores principales: | Jung, Sungwook, Jiang, Liwei, Zhao, Jing, Shultz, Leonard D., Greiner, Dale L., Bae, Munhyung, Li, Xiaofei, Ordikhani, Farideh, Kuai, Rui, Joseph, John, Kasinath, Vivek, Elmaleh, David R., Abdi, Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842032/ https://www.ncbi.nlm.nih.gov/pubmed/36684105 http://dx.doi.org/10.1002/btm2.10273 |
Ejemplares similares
-
Ectopic high endothelial venules in pancreatic ductal adenocarcinoma: A unique site for targeted delivery
por: Bahmani, Baharak, et al.
Publicado: (2018) -
Clathrin Light Chains: Not to Be Taken so Lightly
por: Das, Jyoti, et al.
Publicado: (2021) -
Anti-IL-6 eluting immunomodulatory biomaterials prolong skin allograft survival
por: Uehara, Mayuko, et al.
Publicado: (2019) -
Cargo regulates clathrin-coated pit invagination via clathrin light chain phosphorylation
por: Maib, Hannes, et al.
Publicado: (2018) -
Role of Clathrin Light Chains in Regulating Invadopodia Formation
por: Mukenhirn, Markus, et al.
Publicado: (2021)